Recent methods for measuring dopamine D3 receptor occupancy in vivo: importance for drug development
about
New frontiers in the neuropsychopharmacology of mental illness.Targeting the dopamine D3 receptor: an overview of drug design strategies.Identifying Medication Targets for Psychostimulant Addiction: Unraveling the Dopamine D3 Receptor Hypothesis.Evaluating the Impact of Naltrexone on the Rat Gambling Task to Test Its Predictive Validity for Gambling Disorder.Dopamine D3 receptor binding of (18)F-fallypride: Evaluation using in vitro and in vivo PET imaging studies.Age-related changes in binding of the D2/3 receptor radioligand [(11)C](+)PHNO in healthy volunteers.Exploring the relationship between social attachment and dopamine D2/3 receptor availability in the brains of healthy humans using [11C]-(+)-PHNO.A review of positron emission tomography studies exploring the dopaminergic system in substance use with a focus on tobacco as a co-variate.The dopamine D3 receptor, a quarter century later.PET radiotracer development for imaging high-affinity state of dopamine D2 and D3 receptors: Binding studies of fluorine-18 labeled aminotetralins in rodents.Influence of Nicotine Metabolism Ratio on [11C]-(+)-PHNO PET binding in Tobacco Smokers.Effects of disulfiram on choice behavior in a rodent gambling task: association with catecholamine levels.The effects of buspirone on occupancy of dopamine receptors and the rat gambling task.A Preliminary Investigation of the Effect of Acute Alcohol on Dopamine Transmission as Assessed by [11 C]-(+)-PHNO.Ropinirole and Pramipexole Promote Structural Plasticity in Human iPSC-Derived Dopaminergic Neurons via BDNF and mTOR Signaling.Expression of dopamine D2 and D3 receptors in the human retina revealed by positron emission tomography and targeted mass spectrometry
P2860
Q34198001-C5FAA8F9-55A0-4435-BCFC-13E020E2275AQ34524556-53CDB9EC-493D-4A05-8A9A-5E4758BA7CC6Q35892818-17FB684B-5AD7-476D-B5F3-324BFDA9D42BQ36021014-D8F60B3F-F4C5-497E-9DF2-49DC3D834A7BQ36219773-31E6D13B-B158-4DC3-BD5D-318A4DBAB075Q36730787-296E640A-3FB3-4619-8E99-581D2B5DA1DBQ37662436-7CB41B90-A734-49F9-996E-96F76935E74FQ38789021-167C2E3A-6298-4B33-BA48-496BD90C0674Q38947750-FB2E8958-628E-4DC7-81E0-5BC8708B8260Q45995692-E62F65E8-47F3-46E9-9DFD-9FA5FA89C74BQ47554488-538D58AC-97D9-4863-9FF9-447AF6F879E9Q47585471-07041EB9-AA31-494A-BA04-EEA0DDA686E5Q47642105-C7709A83-CBB4-4688-865B-B3EB2C1D0D7AQ47745261-F7A2C98E-4EA1-42C1-8768-31B18D3CCB2CQ52727018-491ED0E6-6913-47F4-A576-F75D86484DD6Q57138468-0F022BE2-A5E4-4709-9982-3496EEA38F3C
P2860
Recent methods for measuring dopamine D3 receptor occupancy in vivo: importance for drug development
description
2014 nî lūn-bûn
@nan
2014 թուականին հրատարակուած գիտական յօդուած
@hyw
2014 թվականին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Recent methods for measuring d ...... mportance for drug development
@ast
Recent methods for measuring d ...... mportance for drug development
@en
Recent methods for measuring d ...... mportance for drug development
@nl
type
label
Recent methods for measuring d ...... mportance for drug development
@ast
Recent methods for measuring d ...... mportance for drug development
@en
Recent methods for measuring d ...... mportance for drug development
@nl
prefLabel
Recent methods for measuring d ...... mportance for drug development
@ast
Recent methods for measuring d ...... mportance for drug development
@en
Recent methods for measuring d ...... mportance for drug development
@nl
P2093
P2860
P3181
P356
P1476
Recent methods for measuring d ...... mportance for drug development
@en
P2093
Alan A. Wilson
Ariel Graff
Isabelle Boileau
Patricia Di Ciano
P2860
P3181
P356
10.3389/FPHAR.2014.00161
P407
P577
2014-01-01T00:00:00Z